LMRIX | RPFGX | LMRIX / RPFGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 17 years | 34 years | - |
Gain YTD | 16.616 | 28.401 | 59% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 126M | 1.03B | 12% |
Annual Yield % from dividends | 1.38 | 1.70 | 81% |
Returns for 1 year | 17.07 | 29.82 | 57% |
Returns for 3 years | -6.67 | 28.08 | -24% |
Returns for 5 years | 9.30 | 42.17 | 22% |
Returns for 10 years | 60.82 | 81.21 | 75% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FBT | 171.48 | 0.89 | +0.52% |
First Trust NYSE Arca Biotech ETF | |||
JUNW | 30.20 | -0.02 | -0.07% |
AllianzIM U.S. Large Cp Buffer20 Jun ETF | |||
NUEM | 30.29 | -0.04 | -0.13% |
Nuveen ESG Emerging Markets Equity ETF | |||
SPYG | 91.05 | -0.33 | -0.36% |
SPDR® Portfolio S&P 500 Growth ETF | |||
SPXV | 65.83 | -0.24 | -0.36% |
ProShares S&P 500® ex-Health Care |